“Study of the Association between Plasminogen Activator Inhibitor-1, other Inflammatory Markers, Metabolic Control Parameters, and Diabetic Foot Disease”, Biomed. Res. Ther., vol. 9, no. 3, pp. 4986–4995, Mar. 2022, doi: 10.15419/bmrat.v9i3.733.